Navigation Links
2009 Science Report on Genetic Disease Released by Cystinosis Research Foundation
Date:3/9/2009

Researchers of the genetic disease Cystinosis report encouraging news. The Cystinosis Research Foundation has published the third edition of its Science Report, which is designed to provide updates on cystinosis research under way and includes new abstracts of the 12 cystinosis grants issued in 2008. Cystinosis is a rare and fatal metabolic genetic disease that afflicts about 2,000 children worldwide. The CRF Science Report is available at www.cystinosisresearch.org

Irvine, CA (PRWEB) March 9, 2009 -- Researchers of the genetic disease Cystinosis report encouraging news. The Cystinosis Research Foundation has published the third edition of its Science Report, which is designed to provide updates on cystinosis research under way and includes new abstracts of the 12 cystinosis grants issued in 2008. Cystinosis is a rare, genetic and slowly fatal metabolic disease that afflicts about 2,000 children worldwide. The CRF Science Report is available at www.cystinosisresearch.org.

The CRF research teams working on a cure for cystinosis continue to report encouraging news. The research undertaken has "significantly changed the course of cystinosis research and we are moving closer to our mission: to find improved cystinosis treatments and a cure for cystinosis," said Nancy Stack, president of CRF.

The Cystinosis Research Foundation was formed in 2003 and has raised $9.3 million, all of which is committed for medical research. The CRF is the largest fund provider of cystinosis research in the world. Currently, the CRF is funding 25 cystinosis research studies, including seven research fellows in six countries. The foundation has $1.2 million available for new research and plans to issue a global call for research proposals and fellowship grants on March 15, 2009. In 2008, the CRF funded 12 studies with grants totaling $1,741,889.

"The advancements achieved so far are the result of the CRF's focused mission and targeted approaches to cystinosis research. This gets research funds directly into the labs of the world's leading cystinosis doctors and scientists so they can complete their important work. This policy has produced a greater understanding of the disease and the first improvement in treatment to come in more than 25 years," she said.

In patients with cystinosis, the amino acid cystine accumulates in the tissue due to the inability of the body to transport cystine out of the cell. This causes development of crystals, resulting in early cell death.

The genetic disease slowly destroys every organ in the body, including the liver, kidneys, eyes, muscles, thyroid and brain. There is a medicine that prolongs the children's lives, but there is no cure. Almost all sufferers succumb before 40 years old.

Today, with the support of CRF's friends and community the foundation has significantly changed the course of cystinosis research and this genetic disease. CRF's funding efforts have allowed talented doctors and leading cystinosis researchers into initiate novel research studies and advance their cystinosis research efforts. For more information on the organization and its science report call CRF at 949-22-7610 or visit the site.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2208574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Americans United for Life: Rescinding of Conscience Protections for Healthcare Providers Outrageous
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
3. New Book Exposes Junk Science, Conflicts of Interest, Disease Guidelines Affecting Millions
4. HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science
5. Daisyphone, virtual cocoon and smart house at London science conference
6. Crossflo Health Information Exchange Project Presented at HP Health and Life Sciences Symposium
7. Sigma-tau HealthScience Launches www.GlycoCarn.com
8. SpectraScience Receives FDA Clearance for Manufacturing Facility
9. Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
10. Bishops Pro-Life Official Gravely Concerned Over Threat to HHS Conscience Protection Regulation
11. Bill Would Require Nutrition Info on Chain Restaurant Menus and Menu Boards, Says Center for Science in the Public Interest -- News Conference on Tuesday, March 3 in Annapolis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: